Sonodynamic Therapy
SonoTarg’s cancer therapy technology utilises a special type of stimuli responsive drug (sonosensitiser) that only becomes active when it is exposed to ultrasound. Thus it can be injected into the blood stream without producing toxic side effects elsewhere in the body.
Ultrasound can be focused precisely at the site of a tumour, thereby ensuring that the drug is only activated within the target region.